• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿皮质素和促肾上腺皮质激素释放因子(CRF)的高亲和力结合,但促肾上腺皮质激素释放因子不与G蛋白解偶联的促肾上腺皮质激素释放因子受体1(CRFR1)结合。

High-affinity binding of urocortin and astressin but not CRF to G protein-uncoupled CRFR1.

作者信息

Rühmann A, Bonk I, Köpke A K

机构信息

Department of Molecular Neuroendocrinology, Max Planck Institute for Experimental Medicine, Göttingen, Germany.

出版信息

Peptides. 1999 Nov;20(11):1311-9. doi: 10.1016/s0196-9781(99)00136-9.

DOI:10.1016/s0196-9781(99)00136-9
PMID:10612445
Abstract

The structure-activity relationship (SAR) between the recently identified neuropeptide urocortin (Ucn) and corticotropin-releasing factor (CRF) receptor, type 1 (CRFR1), has been investigated. To this end, rat Ucn (rUcn), ovine CRF (oCRF) and chimeric peptides of rUcn and oCRF were synthesized and tested for their binding affinity and potency to stimulate cAMP production in human embryonic kidney (HEK) 293 cells stably transfected with cDNA encoding rat CRFR1 (rCRFR1). In binding studies with [125I-TyrO]oCRF or [3H-Leu9]rUcn as radioligand, it was observed that rUcn but not oCRF bound in a similar fashion as the CRF antagonist astressin with high affinity to rCRFR1 coupled to G protein or uncoupled from G protein by guanosine 5'-O-(3-thiotriphosphate) (GTPgammaS). Consequently, rUcn was found to exert a significantly lower potency than oCRF to stimulate cAMP accumulation in transfected cells. CD spectroscopic investigations and reverse-phase HPLC (RPHPLC) retention behavior of the peptides suggested a more pronounced amphipatic alpha-helical character of rUcn when compared to oCRF and the chimeric peptides.

摘要

最近已对新发现的神经肽尿皮质素(Ucn)与促肾上腺皮质激素释放因子(CRF)受体1型(CRFR1)之间的构效关系(SAR)展开了研究。为此,合成了大鼠Ucn(rUcn)、绵羊CRF(oCRF)以及rUcn和oCRF的嵌合肽,并检测了它们对稳定转染了编码大鼠CRFR1(rCRFR1)的cDNA的人胚肾(HEK)293细胞中刺激cAMP产生的结合亲和力和效力。在用[125I-TyrO]oCRF或[3H-Leu9]rUcn作为放射性配体的结合研究中,观察到rUcn而非oCRF与CRF拮抗剂阿斯特辛以相似方式高亲和力地结合至与G蛋白偶联或通过鸟苷5'-O-(3-硫代三磷酸)(GTPγS)与G蛋白解偶联的rCRFR1。因此,发现rUcn在刺激转染细胞中cAMP积累方面的效力明显低于oCRF。肽的圆二色光谱研究和反相高效液相色谱(RPHPLC)保留行为表明,与oCRF和嵌合肽相比,rUcn具有更明显的两亲性α-螺旋特征。

相似文献

1
High-affinity binding of urocortin and astressin but not CRF to G protein-uncoupled CRFR1.尿皮质素和促肾上腺皮质激素释放因子(CRF)的高亲和力结合,但促肾上腺皮质激素释放因子不与G蛋白解偶联的促肾上腺皮质激素释放因子受体1(CRFR1)结合。
Peptides. 1999 Nov;20(11):1311-9. doi: 10.1016/s0196-9781(99)00136-9.
2
Structure and function of the ovine type 1 corticotropin releasing factor receptor (CRF1) and a carboxyl-terminal variant.绵羊1型促肾上腺皮质激素释放因子受体(CRF1)及其羧基末端变体的结构与功能
Mol Cell Endocrinol. 1998 Sep 25;144(1-2):21-35. doi: 10.1016/s0303-7207(98)00157-9.
3
Novel high-affinity photoactivatable antagonists of corticotropin-releasing factor (CRF) photoaffinity labeling studies on CRF receptor, type 1 (CRFR1).新型促肾上腺皮质激素释放因子(CRF)的高亲和力光可活化拮抗剂:对1型CRF受体(CRFR1)的光亲和标记研究
Eur J Biochem. 2000 May;267(10):3017-24. doi: 10.1046/j.1432-1033.2000.01321.x.
4
Structural requirements for peptidic antagonists of the corticotropin-releasing factor receptor (CRFR): development of CRFR2beta-selective antisauvagine-30.促肾上腺皮质激素释放因子受体(CRFR)肽拮抗剂的结构要求:CRFR2β选择性抗 sauvagine-30 的研发
Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15264-9. doi: 10.1073/pnas.95.26.15264.
5
Binding differences of human and amphibian corticotropin-releasing factor type 1 (CRF(1)) receptors: identification of amino acids mediating high-affinity astressin binding and functional antagonism.人类和两栖类促肾上腺皮质激素释放因子1型(CRF(1))受体的结合差异:介导高亲和力阿斯特辛结合和功能拮抗作用的氨基酸鉴定
Regul Pept. 2004 May 15;118(3):165-73. doi: 10.1016/j.regpep.2003.12.012.
6
The ligand-selective domains of corticotropin-releasing factor type 1 and type 2 receptor reside in different extracellular domains: generation of chimeric receptors with a novel ligand-selective profile.促肾上腺皮质激素释放因子1型和2型受体的配体选择性结构域位于不同的细胞外结构域:具有新型配体选择性特征的嵌合受体的产生。
J Neurochem. 1999 Aug;73(2):821-9. doi: 10.1046/j.1471-4159.1999.0730821.x.
7
Synthesis and characterization of a photoactivatable analog of corticotropin-releasing factor for specific receptor labeling.用于特异性受体标记的促肾上腺皮质激素释放因子光活化类似物的合成与表征
Proc Natl Acad Sci U S A. 1996 Oct 1;93(20):10609-13. doi: 10.1073/pnas.93.20.10609.
8
Comparison of an agonist, urocortin, and an antagonist, astressin, as radioligands for characterization of corticotropin-releasing factor receptors.将促肾上腺皮质激素释放因子受体特征化的放射性配体:激动剂尿皮质素和拮抗剂抗促肾上腺皮质激素释放因子的比较
J Pharmacol Exp Ther. 1999 Feb;288(2):729-34.
9
A soluble form of the first extracellular domain of mouse type 2beta corticotropin-releasing factor receptor reveals differential ligand specificity.小鼠2β型促肾上腺皮质激素释放因子受体首个胞外域的可溶性形式显示出不同的配体特异性。
J Biol Chem. 2003 May 2;278(18):15595-600. doi: 10.1074/jbc.M210476200. Epub 2003 Feb 28.
10
The first extracellular domain of corticotropin releasing factor-R1 contains major binding determinants for urocortin and astressin.促肾上腺皮质激素释放因子受体1的第一个细胞外结构域包含尿皮质素和抗压素的主要结合决定簇。
Endocrinology. 1998 Feb;139(2):566-70. doi: 10.1210/endo.139.2.5757.

引用本文的文献

1
Receptor activity modifying proteins (RAMPs) interact with the VPAC2 receptor and CRF1 receptors and modulate their function.受体活性修饰蛋白(RAMPs)与 VPAC2 受体和 CRF1 受体相互作用,并调节它们的功能。
Br J Pharmacol. 2013 Feb;168(4):822-34. doi: 10.1111/j.1476-5381.2012.02202.x.